CoreMap announces oversubscribed financing to advance next-gen A-fib mapping platform

Vermont Business Magazine CoreMap, Inc, a medical technology company developing advanced tools to improve the treatment of atrial fibrillation (AF of A-fib), announced the closing of its $37 million Series C financing. The oversubscribed round was led by Medtronic and included participation from existing and new investors, reflecting strong confidence in the company and the need for more precise, data-driven tools to guide AF ablation.